Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02773381
Recruitment Status : Completed
First Posted : May 16, 2016
Last Update Posted : December 8, 2020
Sponsor:
Information provided by (Responsible Party):
Novo Nordisk A/S